GSDME and breast carcinoma: They discovered that A-C/NP treatment could trigger GSDME-mediated pyroptosis by disrupting mitochondrial homeostasis and ROS accumulation, resulting in immunogenic cell death and exhibiting potent cytotoxicity in breast cancer cells [135].